Deccan Chronicle

Dec 22 - Kerala Ayurveda Limited (KAL) announced that it has received its first patent from the United States Patent and Trademark Office (USPTO) for a proprietary herbal formulation that is uniquely processed and inspired by ancient ayurvedic wisdom. The company made the announcement during the 9th World Ayurveda Congress and Arogya Expo 2022.

A statistical framework was conducted on the formulation using the rigors of modern scientific validation, including phytochemical and marker analysis, extensive pre-clinical testing at Renovel Discoveries the United States, and a pharma rigor double-blind placebo-controlled clinical study at Banaras Hindu University in India.

The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders such as type 2 diabetes mellitus, obesity, and lipid profile management, as well as its use in the preparation of food supplements, pharmaceuticals, and nutraceuticals in appropriate dosage forms such as beverages/liquids, capsules, tablets, granules, jellies, to mention a few.

Read More